New drug aims to slow blindness from dry AMD

NCT ID NCT05949593

Ongoing Disease control Sponsor: Belite Bio, Inc Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 19 times

Summary

This study tests an experimental drug called tinlarebant in 429 adults with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. The goal is to see if the drug can slow the growth of damaged areas in the eye and preserve vision. Participants receive either the drug or a placebo, and their eye health is tracked over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Belite Study Site

Phoenix, Arizona, 85020, United States
Belite Study Site

Arcadia, California, 91007, United States
Belite Study Site

Beverly Hills, California, 90211, United States
Belite Study Site

Huntington Beach, California, 92467, United States
Belite Study Site

Los Angeles, California, 90033, United States
Belite Study Site

Palo Alto, California, 94303, United States
Belite Study Site

San Diego, California, 92093, United States
Belite Study Site

Lakeland, Florida, 33805, United States
Belite Study Site

Hagerstown, Maryland, 21740, United States
Belite Study Site

Saint Louis Park, Minnesota, 55416, United States
Belite Study Site

Westbury, New York, 11590, United States
Belite Study Site

Cary, North Carolina, 27511, United States
Belite Study Site

Durham, North Carolina, 27710, United States
Belite Study Site

Wake Forest, North Carolina, 27587, United States
Belite Study Site

Portland, Oregon, 97239, United States
Belite Study Site

Philadelphia, Pennsylvania, 19107, United States
Belite Study Site

Sewickley, Pennsylvania, 15143, United States
Belite Study Site

Germantown, Tennessee, 38138, United States
Belite Study Site

Abilene, Texas, 79606, United States
Belite Study Site

Dallas, Texas, 75231, United States
Belite Study Site

San Antonio, Texas, 78240, United States
Belite Study Site

Warrenton, Virginia, 20186, United States
Belite Study Site

Chatswood, New South Wales, 2067, Australia
Belite Study Site

Strathfield, New South Wales, 2135, Australia
Belite Study Site

Brisbane, Queensland, 4101, Australia
Belite Study Site

Adelaide, South Australia, 5000, Australia
Belite Study Site

East Melbourne, Victoria, 3002, Australia
Belite Study Site

Crawley, Western Australia, 6009, Australia
Belite Study Site

Beijing, Beijing Municipality, 100044, China
Belite Study Site

Chengdu, Sichuan, 610093, China
Belite Study Site

Beijing, 10005, China
Belite Study Site

Beijing, 100730, China
Belite Study Site

Guandong, 510060, China
Belite Study Site

Zhejiang, 325027, China
Belite Study Site

Ostrava, 70852, Czechia
Belite Study Site

Prague, 14000, Czechia
Belite Study Site

Prague, 14059, Czechia
Belite Study Site

Dijon, 21000, France
Belite Study Site

Écully, 69130, France
Belite Study Site

Lyon, 69317, France
Belite Study Site

Marseille, 130008, France
Belite Study Site

Basel, 4031, Switzerland
Belite Study Site

Lausanne, 1001, Switzerland
Belite Study Site

Taichung, 40447, Taiwan
Belite Study Site

Taipei, 100, Taiwan
Belite Study Site

Taoyuan, 33305, Taiwan
Belite Study Site

Great Yarmouth, NR31 6LA, United Kingdom
Belite Study Site

Harrow, HA1 3UJ, United Kingdom
Belite Study Site

London, EC1V 2PD, United Kingdom

Conditions

Explore the condition pages connected to this study.

GEOGRAPHIC ATROPHY